1
Immunobiology: The Immune System in Health & Disease
Sixth Edition
Chapter 14
Manipulation of the Immune Response
Copyright © 2005 by Garland Science Publishing
Charles A. Janeway, Paul Travers, Mark Walport, Mark Shlomchik
The structure of the anti-inflammatory corticosteroid drug prednisone
3
Cyclosporin A and tacrolimus inhibit T-cell activation by interfering withthe serine/threonine-specific phosphatase calcineurin
Cyclosporin A and tacrolimus inhibit T-cell activation by interfering withthe serine/threonine-specific phosphatase calcineurin
4
Cyclosporin A and tacrolimus inhibit lymphocyte and some granulocyte responses
Anti-inflammatory effects of anti-TNF-α therapy in rheumatoid arthritis
5
Figure 14-8Natalizumab
Natalizumab, a therapeutic anti-alpha4 integrin mAbfor the treatment of MS and IBD
Figure 14-8 part 1 of 2Natalizumab, an therepeutic anti-alpha4 integrin mAb
for the treatment of MS and IBD
8
Figure 14-10 part 2 of 2
Proteins selectively expressed in human tumors are candidatetumor rejection antigens
9
Tumor rejection antigens may arise by point mutations in self proteins,which occur during the process of oncogenesis
Tumor rejection antigens are peptides of cell proteins presented byself MHC class I molecules
10
Tumors can escape immune surveillance in a variety of ways
Loss of MHC class I expression in a prostatic carcinoma
11
Tumors that lose expression of all MHC class I molecules as a mechanismof escape from immune surveillance are more susceptible to NK cell killing
Monoclonal antibodies that recognize tumor-specific antigens might be usedin a variety of ways to help eliminate tumors
12
Examples of tumor antigens that have been targeted by monoclonalantibodies in therapeutic trials
Transfection of tumors with the gene for B7 or for GM-CSF enhancestumor immunogenicity
13
Transfection of tumors with the gene for B7 or for GM-CSF enhancestumor immunogenicity
Recommended childhood vaccination schedules (in red) in the United States
14
Diseases for which effective vaccines are still needed
There are several criteria for an effective vaccine